CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III QWINT development program found. In QWINT-1, there was a similar ...
The US Food and Drug Administration has approved insulin icodec (Awiqli), developed by Novo Nordisk, as the first once-weekly long-acting basal insulin for glycemic control in adults with Type ...
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration on Monday approved Insulet's Omnipod 5 automated insulin delivery system for people with Type 2 ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with type 2 diabetes lowered their HbA1c from ...
Everyday Health on MSN
Do you still need insulin for type 2 diabetes in the Ozempic era?
Learn how GLP-1s are changing type 2 diabetes care, when insulin therapy is still necessary, and the benefits of combining ...
Add Yahoo as a preferred source to see more of our stories on Google. On Monday the U.S. Food and Drug Administration (FDA) announced that it has cleared the way for the first medical device that ...
The doctors at fictional Sacred Heart Hospital are in, and so is Insulet’s real-life wearable insulin management system ...
The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.
Obesity and type 2 diabetes are complex metabolic disorders linked to insulin resistance in skeletal muscle. Weight loss, a fundamental treatment for these conditions, has been shown to improve ...
A surprising new clinical trial has revealed that metformin—a cheap, century-old drug widely used for type 2 diabetes—may help people with type 1 diabetes in an unexpected way. While researchers ...
Aug. 26 (UPI) --The Food and Drug Administration on Monday approved Insulet's Omnipod 5 automated insulin delivery system for people with Type 2 diabetes. In 2022, the FDA signed off on the system for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results